Demand on the rise for EMR-dedicated scribes

The Affordable Care Act is swelling patient rolls while CMS continues slapping EMR-resistant providers with increasingly hefty financial penalties. What’s an already overburdened doctor to do?

Hire a medical scribe.

According to a feature article in the Sacramento Bee, that’s exactly what a growing number of physicians, hospitals and clinics are doing.

Job 1 on the role’s to-do list is entering key details of each and every patient encounter into the EMR in a timely manner.

The article cites a Mayo Clinic study published last month showing that more than half of physicians nationwide experience professional burnout, and the condition significantly worsened from 2011 to 2014.

It quotes Justin Wagner, MD, medical director of Sutter Health’s emergency department, which employs about 40 scribes.

“As time goes on, the landscape of healthcare becomes more complicated,” Wagner told the Bee. “Scribes can help reduce that burden for physicians. They’re worth their weight in gold, for sure.”

Read the whole thing.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.